Platelet monoamine oxidase activity in underweight and weight-recovered females with anorexia nervosa

Pharmacopsychiatry

Volumn 41, Issue 6, 2008, Pages 226-231

  Ehrlich, Stefan ^a   Franke, L ^a   Schott, R ^a   Salbach Andrae H ^a   Pfeiffer, E ^a   Lehmkuhl, U ^a   Uebelhack, R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); LEPTIN;

ACUTE DISEASE; ADOLESCENT; ADULT; ANALYSIS OF COVARIANCE; ANOREXIA NERVOSA; ANXIETY; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALNUTRITION; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE; UNDERWEIGHT;

ADIPOCYTES; ADOLESCENT; ADULT; ANOREXIA NERVOSA; BLOOD PLATELETS; BODY WEIGHT; EATING; ENERGY METABOLISM; FEMALE; GONADS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LEPTIN; MONOAMINE OXIDASE; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN; THINNESS; YOUNG ADULT;

EID: 58049088941     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1078749     Document Type: Article

References (47)

1. Anderson IM, Parry-Billings M, Newsholme EA, Fairburn CG, Cowen PJ. Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol Med 1990; 20: 785-791
2. Bandelow B, Stein DJ, Dolberg OT, Andersen HF, Baldwin DS. Improvement of quality of life in panic disorder with escitalopram, citalopram, or placebo. Pharmacopsychiatry 2007; 40: 152-156
3. Biederman J, Baldessarini RJ, Harmatzz JS et al. Heterogeneity in anorexia nervosa. Biol Psychiatry 1986; 21: 213-216
4. Biederman J, Rivinus TM, Herzog DB et al. Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder. Am J Psychiatry 1984; 141: 1244-1247
5. Blundell JE, Lawton CL, Halford JC. Serotonin, eating behavior, and fat intake. Obes Res 1995; 3 (Suppl 4): 471S-476S
6. Brewerton TD, Jimerson DC. Studies of serotonin function in anorexia nervosa. Psychiatry Res 1996; 62: 31-42
7. 3H]paroxetine binding in anorexia nervosa: relationship to eating symptoms and personality pathology. Psychiatry Res 2006; 142: 225-232
8. Carrasco JL, Diaz-Marsa M, Hollander E, Cesar J, Saiz-Ruiz J. Decreased platelet monoamine oxidase activity in female bulimia nervosa. Eur Neuropsychopharmacol 2000; 10: 113-117
9. Chen K, Wu HF, Shih JC. The deduced amino acid sequences of human platelet and frontal cortex monoamine oxidase B are identical. J Neurochem 1993; 61: 187-190
10. Demitrack MA, Heyes MP, Altemus M, Pigott TA, Gold PW. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable. Biol Psychiatry 1995; 37: 512-520
11. Diaz-Marsa M, Carrasco JL, Hollander E, Cesar J, Saiz-Ruiz J. Decreased platelet monoamine oxidase activity in female anorexia nervosa. Acta Psychiatr Scand 2000; 101: 226-230
12. Fahlke C, Garpenstrand H, Oreland L, Suomi SJ, Higley JD. Platelet monoamine oxidase activity in a nonhuman primate model of type 2 excessive alcohol consumption. Am J Psychiatry 2002; 159: 2107
13. Fichter M, Quadflieg N. SIAB. Strukturiertes Inventar für Anorektische und Bulimische Essstörungen nach DSMAV und ICD-10. Bern: Huber 1999
14. Fichter M, Quadflieg N. The structured interview for anorexic and bulimic disorders for DSM-IV and ICD-10 (SIAB-EX): reliability and validity. Eur Psychiatry 2001; 16: 38-48
15. Fowler CJ, Ekstedt B, Egashira T, Kinemuchi H, Oreland L. The interaction between human platelet monoamine oxiclase, its monoamine substrates and oxygen. Biochem Pharmacol 1979; 28: 3063-3068
16. Fowler JS, Logan J, Wang GJ, Volkow ND. Monoamine oxidase and cigarette smoking. Neurotoxicology 2003; 24: 75-82
17. Frank GK, Kaye WH, Meltzer CC et al. Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biol Psychiatry 2002; 52: 896-906
18. Franke GH. 2. SCL-90-R. Symptorn-Checkliste von L. R. Derogatis - Deutsche Version. Göttingen: Beltz Test GMBH 2002
19. Gundlah C, Lu NZ, Bethea CL. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl) 2002; 160: 271-282
20. Hallman J, Sakurai E, Oreland L. Blood platelet monoamine oxidase activity, serotonin uptake and release rates in anorexia and bulimia patients and in healthy controls. Acta Psychiatr Scand 1990; 81: 73-77
21. Hassanyeh F, Marshall EF. Measures of serotonin metabolism in anorexia nervosa. Acta Psychiatr Scand 1991; 84: 561-563
22. Hebebrand J, Muller TD, Holtkamp K, Herpertz-Dahlmann B. The role of leptin in anorexia nervosa: clinical implications. Molecular Psychiatry 2007; 12: 23-35
23. Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol Behav 2008; 94: 121-135
24. Kaye WH, Bulik CM, Thornton L, Barbarich N, Masters K. Comorbiclity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry 2004; 161: 2215-2221
25. Kaye WH, Ebert MH, Raleigh M, Lake R. Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch Gen Psychiatry 1984; 41: 350-355
26. Kaye WH, Frank GK, Bailer UF et al. Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiol Behav 2005; 85: 73-81
27. Kaye WH, Gwirtsman HE, George DT, Ebert MH. Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Arch Gen Psychiatry 1991; 48: 556-562
28. Kennedy SH, Kaplan AS, Garfinkel PE et al. Depression in anorexia nervosa and bulimia nervosa: discriminating depressive symptoms and episodes. J Psychosom Res 1994; 38: 773-782
29. Kromeyer-Hauschild K, Wabitsch M, Kunze D et al. Perzentile für den Body Mass Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift für Kinderheilkunde 2001; 149: 807-818
30. Lam RW, Andersen HF. The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: an extended analysis. Pharmacopsychiatry 2006; 39: 180-184
31. Leibowitz SF. The role of serotonin in eating disorders. Drugs 1990; 39 (Suppl 3): 33-48
32. Monteleone P, Brambilla F, Bortolotti F, La Rocca A, Maj M. Prolactin response to d-fenfluramine is blunted in people with anorexia nervosa. Br J Psychiatry 1998; 172: 439-442
33. Oreland L. Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection. Neurotoxicology 2004; 25: 79-89
34. Oreland L, Fowler CJ, Schalling D. Low platelet monoamine oxidase activity in cigarette smokers. Life Sci 1981; 29: 2511-2518
35. Oreland L, Shaskan EG. Some rational behind the use of monoamine oxiclase activity as a biological marker. Trends in Pharmacological Sciences 1983; 4: 339-341
36. Podar I, Jaanisk M, Allik J, Harro J. Psychological traits and platelet monoamine oxidase activity in eating disorder patients: their relationship and stability. Progress in neuro-psychopharmacology & biological psychiatry 2007; 31: 248-253
37. Rathner G, Waldherr K. Eating Disorder Inventory-2. Eine deutschsprachige Validierung mit Normen für weibliche und männliche Jugendliche. Zeitschrift für Klinische Psychologie, Psychiatrie und Psychotherapie 1997; 45: 157-182
38. Richards JG, Saura J, Luque JM et al. Monoa mine oxidases: from brain maps to physiology and transgenics to pathophysiology. J Neural Transm Suppl 1998; 52: 173-187
39. Ruchkin VV, Koposov RA, af Klinteberg B, Oreland L, Grigorenko EL. Platelet MAO-B, personality, and psychopathology. J Abnorm Psychol 2005; 114: 477-482
40. Singer TP, Ramsay RR. Flavoprotein structure and mechanism 2. Monoamine oxidases: old friends hold many surprises. Faseb J 1995; 9: 605-610
41. Uebelhack R, Franke L, Schewe HJ. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava). Pharmacopsychiatry 1998; 31: 187-192
42. Whitfield JB, Pang D, Bucholz KK et al. Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology. Psychol Med 2000; 30: 443-454
43. 2+ response in patients with anorexia nervosa. Pharmacopsychiatry 2008; 41: 10-16
44. Wonderlich SA, Lilenfeld LR, Riso LP, Engel S, Mitchell JE. Personality and anorexia nervosa. The International journal of eating disorders 2005; 37 (Suppl): S68-71; discussion S87-69
45. Youdim MB. Platelet monoamine oxidase B: use and misuse. Experientia 1988; 44: 137-141
46. Youdim MB, Riederer P. Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition. J Neural Transm Gen Sect 1993; 91: 181-195
47. Zhang F, Chen Y, Heiman M, Dimarchi R. Leptin: structure, function and biology. Vitam Horm 2005; 71: 345-372